CONTRIBUTION OF CLINICAL PHARMACIST IN AN EXPERIENCE FEEDBACK COMMITTEE: OUTCOMES AT 9 MONTHS OF ANALYSIS OF DRUG PRESCRIPTIONS FOR PATIENT ‘FALLERS’